| ICD-9-CM: |
| 210 - | Neoplasm, Lip, Oral Cavity, and Pharynx, Benign |
| 210.2 - | Benign Neoplasm of Major Salivary Glands |
| 211 - | Neoplasm, Other Parts of Digestive System, Benign |
| 211.3 - | Polyp of Colon |
| 212 - | Neoplasm, Respiratory and Intrathoracic Organs, Benign |
| 213 - | Benign Neoplasm of Bone and Articular Cartilage |
| 217 - | Neoplasm, Benign Breast Nipple |
| 220 - | Benign Neoplasm of Ovary |
| 223 - | Benign Neoplasm of Kidney and Other Urinary Organs |
| 223.3 - | Benign Neoplasm of Kidney and Other Urinary Organs; Bladder |
| 225 - | Benign Neoplasm of Brain and Other Parts of Nervous System |
| 225.0 - | Benign Neoplasm of Brain and Other Parts of Nervous System; Brain |
| 225.1 - | Benign Neoplasm of Brain and Other Parts of Nervous System; Cranial Nerves |
| 225.2 - | Benign Neoplasm of Brain and Other Parts of Nervous System; Cerebral Meninges; Meninges NOS; Meningioma, Cerebral |
| 226 - | Benign Neoplasm of Thyroid Glands |
| 227 - | Benign Neoplasm of Other Endocrine Glands and Related Structures |
| 227.4 - | Benign Neoplasm of Other Endocrine Glands and Related Structures; Pineal Gland; Pineal Body |
| 229 - | Neoplasm, Other and Unspecified Sites, Benign |
| 229.8 - | Benign Neoplasm of Other and Unspecified Sites; Other Specified Sites; Intrathoracic NOS; Thoracic NOS |
| 229.9 - | Neoplasm, Benign; Site Unspecified |
A benign tumor or neoplasm is a non-cancerous (non-malignant) abnormal mass of tissue that forms when cells in a localized area reproduce at an increased rate. The cells are derived from normal cells, but undergo changes that make them unresponsive to the biologic normal controls that limit growth. These cells continue to grow faster than the surrounding tissue, resulting in a tumor. Benign tumors can develop in almost any body organ and are found in the kidneys, liver, lungs, heart, brain, bone, uterus, testicles, ears, salivary glands, and on the skin. They usually are small (less than 1 cm in diameter) and are firm. Benign tumors often are discovered incidentally when another condition is being investigated. Many are found during exploratory surgery (laparotomy), or during an autopsy.
The two basic types of tumors, benign tumors and cancerous (malignant) tumors, are distinguished by their cell types, growth patterns, and effects on the body. Benign tumors grow as well-defined masses that push normal cells out of the way rather than invading surrounding tissue; they tend to be restricted to a limited area (localized). Cells in malignant tumors tend to invade surrounding tissue and also to migrate to other locations in the body (metastasize). Unlike malignant tumor cells, the cells in benign tumors do not metastasize or invade the vascular or lymph systems, although they can grow in ways that interfere with normally functioning tissue if they become large enough to press on nearby structures. Benign tumors may block a blood vessel, impinge on a nerve, or grow in a vital area of the brain where they may compress neurovascular structures, thus causing other clinical problems. (See also lipoma, meningioma, and neurofibroma).
A benign tumor may form a capsule of connective tissue around itself that separates the tumor from adjacent normal cells. Growth of a benign tumor is usually slow; a tumor may not increase in size for months or years. Symptoms may not appear until the tumor grows to the point at which it presses on or disturbs nerves, blood vessels, or other organs. Compression of other structures can be particularly dangerous in confined spaces such as inside the skull, heart, or lungs. Rarely, benign tumors can become malignant.
Risk: It is unclear what causes the development of benign tumors. Many factors, including environmental toxins, genetic influences, diet, emotional stress, local trauma or injury, and inflammation are thought to be possible causes, either singly or in combination. In some cases, particularly if hormone receptors are present on the multiplying cells, gender may be a factor in the development of certain types of benign tumors (e.g., women are subject to the development of hormone-related uterine tumors called fibroids). Nevertheless, most benign tumors occur with equal frequency in both sexes and can develop in almost any region of the body.
Incidence and Prevalence: Since many benign tumors are asymptomatic, incidence is difficult to determine. Benign tumors represent about 2% to 5% of all tumors found in the lungs, and up to 50% can later become malignant (Gould).
|
Source: Medical Disability Advisor
History: Symptoms depend on the cell type of origin, size and location of the growth, and the organ system involved. Individuals may report noticing a lump or skin change. If an abdominal tumor is pressing on the stomach or nearby structures, individuals may complain of nausea, a sense of fullness, or weight loss. When tumors compress or disturb nerves, they can cause pain or disorders such as dizziness, unsteadiness, vision problems, weakness, or headaches.
Physical exam: Physical findings vary according to the site and size of the tumor. Examination may reveal a lump or skin change when the tumor is located in the soft tissue such as the breast, abdomen, muscle, or skin. However, if the tumor is small and is located in a deep structure such as the lungs, brain, or other organs, no physical abnormalities may be found.
Tests: Diagnostic imaging may be used to visualize internal organs and to determine the location and size of a suspected tumor. X-ray, ultrasound, high resolution computed tomography (CT), or magnetic resonance imaging (MRI) may be used either alone or in combination to examine tissue in more detail, depending on location involved. Direct inspection of certain internal organs may require the use of an endoscope, a small, lighted fiberoptic instrument that is passed into the organ or cavity being examined. This minimally invasive technique is used most often for examinations of abdominal or pelvic organs such as the colon (colonoscopy), stomach and adjacent organs of the gastrointestinal tract (gastroscopy), bladder (cystoscopy), and abdominal cavity (laparoscopy). Thoracotomy or thorascopy may be used to examine the lungs.
Differentiating between benign and malignant tumors requires an evaluation of tumor cells by a pathologist (histopathologic examination). Diagnosis usually is confirmed by microscopic examination of tumor tissue cells that have been removed surgically (biopsy) or aspirated by needle biopsy and stained by appropriate techniques. For example, up to 50% of benign lesions in the lung are identified by biopsy and cell differentiation study (Gould). Differentiation refers to the extent to which cells resemble the normal cells of origin in terms of size, morphology, and function. Differentiation can range from well-differentiated, as in benign lesions, to moderately well differentiated, which can be either benign or malignant, to cells showing much less differentiation (anaplastic), or undifferentiated; anaplastic and undifferentiated lesions are characteristically malignant with many changes in size, shape, and degree of proliferation. Benign tumor cells retain many of the same features as the cells of the tissue from which they arose, although the tumor tissue typically will be denser than normal tissue, and cell proliferation will be less than in malignant tumors.
Distinguishing between a benign and malignant lesion also depends on the presence of metaplasia or dysplasia in the tissue. Metaplasia describes a condition of tissue damage, repair, and regeneration of cells; however, the replacement cells are not of the same type as the original tissue. The cells in the tumor are abnormal and have differentiated into tissue of another kind. Dysplasia refers to disordered growth that includes loss of uniformity among cells and changes in their composition that are typical of malignant neoplasms.
|
Source: Medical Disability Advisor
The treatment of choice usually is to surgically remove (resect) the tumor, preferably with endoscopic techniques rather than open surgery. Indications for surgery include the presence of symptoms, radiographic evidence of tumor growth, or a large tumor that is compromising function of a vital structure. The type of surgery performed is specific to the location of the tumor and the anatomic area affected by the tumor. Most benign tumors can be completely resected, reduced in size by removing part of the tumor, or destroyed using other types of treatment. If the tumor is located in an inaccessible area, radiation therapy can slow or destroy the production and development of abnormal cells. Meningiomas, which are benign central nervous system tumors, usually are surgically removed unless they are either of a recurrent type or are in a location where complete resection is not possible. In these cases, the benign tumor is treated by either conventional external radiation therapy or by a more focused stereotactic radiosurgery technique. In certain organs such as the uterus, the combination of ultrasound and a probe that freezes the tumor (cryotherapy) may be used to retard tumor growth. Certain systemic treatments, such as drug therapies that inhibit cell growth, are used to retard the growth of benign tumors in individuals whose health is compromised by other conditions and who are not candidates for surgery.
Some benign tumors, such as fatty tumors (lipomas) between the skin and underlying muscle, produce no symptoms and do not need to be removed unless they are painful, cumbersome, or are pressing on a nerve or blood vessel.
|
Source: Medical Disability Advisor
The outcome following surgical removal of a benign tumor usually is good if the tumor is located in an accessible area. Symptoms usually are relieved with the removal of the tumor. Some benign tumors have the potential to become malignant and can begin to infiltrate surrounding tissue. If a benign tumor cannot be removed, radiation therapy or cryotherapy often can slow or destroy the production and development of abnormal cells. Morbidity and mortality are low when comparing benign tumors to malignant ones.
|
Source: Medical Disability Advisor
The site of the tumor and extent of the disease determine complications. Benign tumors can obstruct passageways, press on nerves and cause nervous system disorders, disrupt the function of a vital organ, cause mental and physical disabilities, and may result in death. Brain tumors may have serious complications such as neurological deficit because of pressure on normal brain tissue. A brain tumor on the lining of the brain (meningioma) may be incurable if it infiltrates brain tissue or is in a location where it cannot be surgically removed or treated with radiation. Hemorrhage and tissue death (necrosis) are other possible complications with benign tumors.
|
Source: Medical Disability Advisor
The location of the tumor and type of surgical or other treatment dictate any work restrictions or accommodations needed. Individuals receiving radiologic therapy to reduce tumor size may require time off to receive and recover from treatments.
|
Source: Medical Disability Advisor
| If an individual fails to recover within the expected maximum duration period, the reader may wish to consider the following questions to better understand the specifics of an individual's medical case. Regarding diagnosis:
- Was individual symptomatic?
-
Was presence of a tumor determined with a physical exam and diagnostic tests (CT, ultrasound, MRI)? Endoscopic examination such as laparoscopy, thorascopy, colonoscopy, or cystoscopy?
-
Was diagnosis of benign tumor confirmed with a biopsy?
-
Were conditions with similar symptoms, such as malignancy, foreign body or abscess, ruled out?
-
Was tumor interfering with normal function of adjacent organs or structures?
-
Was tumor accessible for surgical removal or treatment with radiation?
Regarding treatment:
- Was the tumor surgically removed? Was surgeon able to remove all the abnormal tissue?
-
If the tumor is inaccessible, has radiation therapy been given?
-
How effective has radiation therapy been in halting or slowing the growth of the tumor?
-
Is cryotherapy a viable alternative treatment for this tumor?
-
Is individual a candidate for tumor-inhibiting drug therapy?
Regarding prognosis:
- Was the tumor successfully removed?
-
If the surgeon was not able to remove all the tissue, what impact does the remaining tissue have on function?
-
Did surgery reduce or alter individual's functional capabilities?
-
Has individual received appropriate follow-up care to monitor the status of the tumor?
-
Has tumor stopped growing? Recurred?
-
Does individual have an underlying condition (underlying chronic illness, organ dysfunction, bleeding disorder or immune suppression) that may affect recovery?
-
Have complications of tumor growth or treatment developed? Are they being treated?
|
Source: Medical Disability Advisor
| CitedGould, Michael, and Norman W. Rizk. "Benign Tumors." Murray & Nadel’s Textbook of Respiratory Medicine. Eds. Robert J. Mason, et al. 4th ed. Saunders Elsevier, 2005. MD Consult. Elsevier, Inc. 8 Sep. 2009 <http://mdconsult.com>. |
| GeneralStricker, Thomas, and Vinay Kumar. "Characteristics of Benign and Malignant Neoplasms." Robbins and Cotran Pathologic Basis of Disease. Eds. Vinay Kumar, et al. 8th ed. Saunders Elsevier, 2009. MD Consult. Elsevier, Inc. 8 Sep. 2009 <http://mdconsult.com>. |
Source: Medical Disability Advisor
| Feedback |
| Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must
include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment.
If you are seeking medical advice, please contact your physician. Thank you! |
Send this comment to:
Sales
Customer Support
Content Development
|
|
| |
|
|
|
|
|
This publication is designed to provide accurate and authoritative information in
regard to the subject matter covered. It is published with the understanding that
the author, editors, and publisher are not engaged in rendering medical, legal,
accounting or other professional service. If medical, legal, or other expert assistance
is required, the service of a competent professional should be sought. We are unable to respond to requests for advice.
Any Sales inquiries should include an email address or other means of
communication.
|